Viome partners with Microsoft to scale its RNA-based health platform, using AI and cloud computing to deliver personalized ...

A collaboration between Viome Life Sciences and Scripps Research is set to develop and clinically validate the first ribonucleic acid (RNA) test aimed at detecting precancerous colon polyps. This ...

Viome Life Sciences, a biotechnology company founded in 2016, has launched CancerDetect, a diagnostic test for oral and throat cancer that uses mRNA technology and an AI-powered platform, the ...

Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...

Viome is combining science and AI to provide dietary advice and detect diseases. Two company execs share how they use the MVP mindset for innovation.

Viome Life Sciences, a leader in AI-powered, RNA-based molecular diagnostics and personalized nutrition, today announced a ...

Study aims to enhance colorectal cancer prevention by identifying polyp molecular signals, offering improved sensitivity over at-home DNA tests, which have limited ability to detect precancerous ...

Viome's Full Body Intelligence Test ™ is the only science backed at-home test that decodes your body's biological signals to give you precision health insights. It reveals not just what's ...

Viome has launched its personalized day and night toothpaste and gel, formulated using oral microbiome data and artificial intelligence. The MyBiotics toothpaste and gel is designed to function as ...

Viome’s audacious promise to customers is that it can analyze their saliva, stool, or blood and produce health reports on their microbiome, accompanied by personalized dietary and supplement ...